Skip to main content

flagFor US Healthcare Professionals Only

Quick Links

  • Prescribing Information
    • CIMZIA® (certolizumab pegol)
  • Adverse Event Reporting
    • Report an Adverse Event or Product Complaint
    • Online Web Form
    • Email
    • 1-844-599-CARE (2273)
  • Connect with a MSL
  • Connect With Us
Home

Main navigation

  • Home
  • Our Science
    • Publications
    • Immunology Pipeline
    • Opportunities for Investigators
  • Disease Education
    • Dermatology
    • Rheumatology
    • Podcasts
  • Congress Materials
  • Medical Information
  • HCP Resources
  • Prescribing Information
  • CIMZIA® (certolizumab pegol)
  1. Home

Disease Education

Dermatology
icon
Rheumatology
icon
Podcasts

Footer Logo

Footer Left

  • UCB-Cares.com
  • UCB-USA.com
  • UCB.com

CIMZIA® and UCBCOMPASS®  are registered trademarks of the UCB Group of Companies. All other trademarks and registered trademarks are the property of their respective holders.

©2022 UCB, Inc. All rights reserved. All data collected on this site is governed by UCB's Privacy Policy, Cookies Policy, as well as the site Terms and Conditions. This site is intended for US Healthcare Professionals only.

US-S-BK-AS-2200006

Sticky notice

Announcements

UCB continues to proactively monitor the COVID-19 situation. To learn more about UCB's preparedness, click here.

FDA issues a Complete Response letter to the Biologics License Application for bimekizumab for the treatment of moderate-to-severe plaque psoriasis. Learn more.

The Women's Health Fellowship Program began accepting applications for the 2024-2025 fellowship year on May 8th. Learn More

You are now leaving UCBCOMPASS®

UCBCOMPASS® offers links to third party websites provided solely for your convenience that may assist you in locating other useful information. UCB is not responsible for content or privacy policies on linked third-party websites that are not under the control of UCB. Do you wish to continue?
CancelYes, Continue

This site is intended for Healthcare Professionals licensed in the United States.

UCBCOMPASS® provides accurate, unbiased, and non-promotional scientific education and medical information on UCB products and disease areas of focus. This content is for informational purposes only and is not intended as medical advice. It may include information about products or uses that have not been approved by the U.S. Food and Drug Administration.

Notice about cookies
This website uses a limited number of cookies to improve your browsing experience. For further information (including how to withdraw consent), please refer to our Cookie Policy.

By clicking “Confirm” I certify that I am a U.S. Healthcare Professional and have read and consent to this site’s use of cookies.
I am a patient or caregiverI am a non-U.S. Healthcare Professional

Footer Right

  • contactAll
    • REPORT AE
    • CONTACT US
    • MSL CONNECT
  • Home
  • Contact Us
  • Site Map

Footer Image

TOP